Jared Freedberg

General Counsel, IMMUNOMEDICS INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Nov 8, 2023Returned to company 33,762 shares at $19.00 of Intercept Pharmaceuticals²
Nov 8, 2023U 22,681 shares at $19.00 of Intercept Pharmaceuticals²
Nov 1, 2023Shares withheld for tax 771 shares at $18.96 of Intercept Pharmaceuticals³
Aug 1, 2023Shares withheld for tax 771 shares at $10.50 of Intercept Pharmaceuticals⁴
May 1, 2023Shares withheld for tax 771 shares at $17.07 of Intercept Pharmaceuticals⁵
Feb 1, 2023Shares withheld for tax 918 shares at $18.76 of Intercept Pharmaceuticals⁶
Jan 27, 2023Granted 12,200 shares of Intercept Pharmaceuticals⁷
Dec 31, 2022Shares withheld for tax 718 shares at $12.37 of Intercept Pharmaceuticals⁸
Nov 1, 2022Shares withheld for tax 771 shares at $15.73 of Intercept Pharmaceuticals⁹
Aug 1, 2022Shares withheld for tax 771 shares at $12.21 of Intercept Pharmaceuticals¹⁰
May 1, 2022Shares withheld for tax 771 shares at $15.71 of Intercept Pharmaceuticals¹¹
Feb 1, 2022Shares withheld for tax 4,072 shares at $16.91 of Intercept Pharmaceuticals¹²
Jan 27, 2022Granted 10,300 shares of Intercept Pharmaceuticals¹³

The numbers on this page point here. Each one links to the record it came from.